World Trade Factory™

AstraZeneca, Cellectis targeted in patent lawsuit over gene-editing technology

AstraZeneca, Cellectis targeted in patent lawsuit over gene-editing technology

Biotech company Factor Bioscience sued rival Cellectis and pharmaceutical giant AstraZeneca in Delaware federal court on Friday for allegedly infringing three patents related to gene-editing technology used in cancer treatments.

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.